Biomedical Nanostructures 2007
DOI: 10.1002/9780470185834.ch5
|View full text |Cite
|
Sign up to set email alerts
|

Nanotechnology and Drug Delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…It is noteworthy to mention that the largest size of rigid particles to safely circulate within the capillaries is around 5 μm, whereas the largest particle to be up taken by cell can be up to 500 nm . In the case of cancer drug delivery, even large nanocarriers with sizes of ∼400 nm are demonstrated to take advantage of enhanced permeation and retention effect (EPR effect) for passive tumor targeting. The developed Sblg-f-MWCNTs exhibit average particle size of ∼315 nm.…”
Section: Discussionmentioning
confidence: 99%
“…It is noteworthy to mention that the largest size of rigid particles to safely circulate within the capillaries is around 5 μm, whereas the largest particle to be up taken by cell can be up to 500 nm . In the case of cancer drug delivery, even large nanocarriers with sizes of ∼400 nm are demonstrated to take advantage of enhanced permeation and retention effect (EPR effect) for passive tumor targeting. The developed Sblg-f-MWCNTs exhibit average particle size of ∼315 nm.…”
Section: Discussionmentioning
confidence: 99%